Neutropenia Secondary to AML Treatment
Neutropenia Secondary to AML Treatment: Neutropenia is a severe reduction in neutrophil count, a type of white blood cell essential for fighting infections. In patients
acute myeloid leukemia
Acute Myeloid Leukemia with Isocitrate Dehydrogenase-2 (IDH2) Mutation
Acute Myeloid Leukemia with Isocitrate Dehydrogenase-2 (IDH2) Mutation is a complex and aggressive hematologic malignancy characterized by the uncontrolled proliferation of abnormal myeloid cells. Among
Acute Myeloid Leukemia with Isocitrate Dehydrogenase-1 (IDH1) Mutation
Acute Myeloid Leukemia with Isocitrate Dehydrogenase-1 (AML) is a heterogeneous hematologic malignancy characterized by the clonal proliferation of myeloid progenitor cells. Among the various genetic
Acute Myeloid Leukemia with FLT3 Mutation
Acute Myeloid Leukemia with FLT3 Mutation is a hematologic malignancy characterized by the uncontrolled proliferation of myeloid precursor cells. Among its genetic mutations, the FMS-like
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive form of blood cancer characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and
cd33 positive acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by clonal proliferation of myeloid precursors. Among the various subtypes, CD33-positive AML represents a critical